| abstract |
The invention relates to polypeptide tetramers as well as effector domains (such as antigen binding sites (eg, antibodies or TCR binding sites that specifically bind to antigen or pMHC, or variable domains thereof)) or incretin, insulin or hormone peptides And multimers such as tetramers and octamers of peptides. [Selection diagram] Fig. 1 |